Financing deals

CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Derived from Current Agreements, our editors have selected notable financing deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.

For comprehensive access to all life science deals as they are announced:

Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now

Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now

Featured financing deals

All financing deals: Deal Monitor | Current Agreements

Public offering of common stock for $100.6 million

June 16, 2011 : financings

AVEO Pharmaceuticals has announced the pricing of an underwritten public offering of 5,750,000 shares of its common stock at a price of $17.50 per share to the public. more »

GSK to buy $129.4m in Theravance stock

November 29, 2010 : big pharma, GlaxoSmithKline

GlaxoSmithKline PLC will buy about $129.4 million worth of stock in Theravance Inc. in a private placement. London-based Glaxo agreed to buy 5.75 million shares for $22.50 each. The purchase increases Glaxo’s stake in South San Francisco-based Theravance to 19 percent. more »

Sanofi completes $10m equity investment in Regulus

October 28, 2010 : big pharma, Sanofi

Regulus Therapeutics Inc. has announced that the Company has received a $10 million equity investment from sanofi-aventis in connection with the landmark alliance the two companies entered into on June 21, 2010. more »

Shanghai Pharma taps banks for $1.5bn HK IPO sources

October 18, 2010 : big pharma, Roche

Shanghai Pharmaceuticals Holding Co Ltd., the Chinese partner of Roche Holding AG plans to raise $1.2 billion to $1.5 billion in a Hong Kong IPO in the second quarter of 2011, sources close to the deal said. more »

Lilly prepares to inject $150m into three new biotech funds

September 9, 2010 : big pharma, Eli Lilly

Following a series of bitter setbacks in the clinic, Eli Lilly plans to add $150 million to three new biotech venture capital funds that would total $750 million. more »

Top 5 biotech VC deals H1 2010

July 28, 2010 :

The first half of 2010 has drawn to a close, so it’s time to look back on the biggest biotech venture capital deals so far this year. more »

Actavis inks key refinancing deal

July 22, 2010 : Actavis, big pharma

Icelandic generic drugmaker Actavis has agreed to a debt refinancing deal with its lenders to slash its multibillion-euro debt load. more »

Biotech takes top spot in Q2 VC investment

July 16, 2010 :

The National Venture Capital Association (NVCA) has released second quarter investment numbers, and once again the life sciences sector (biotechnology and medical device industries combined) leads the pack. more »

Pfizer venture arm joins $25m round for Aquinox

June 17, 2010 : big pharma, J&J, Pfizer

Pfizer Venture Investments has joined a group of venture groups to provide a $25 million Series B round for Aquinox Pharmaceuticals, a Canadian start-up working on anti-inflammatories. more »

« Page 1 ... 104, 105, 106, »

Derived from Current Agreements, more featured partnering deals by category:

Big pharma

Bristol-Myers Squibb in Mutli Year strategic pharma alliances deal with Prosetta Antiviral

August 1, 2012

Roche signs a technology transfer pharma partnering pact with SynenTec

August 1, 2012

Big pharma GlaxoSmithKline ejects executives from recently acquired Human Genome Sciences

August 1, 2012

View more featured deals | all deals at Deal Monitor

Big biotech

Blog in Blog: There are no posts that match the selection criteria.View more featured deals | all deals at Deal Monitor

Pharma

Catalent Pharma announce equity repurchase for $350 million

September 7, 2012

Secong spin-off company from big pharma, Merck Serono

September 7, 2012

Synairgen in hunt for pharma partners to develop asthma drug

September 6, 2012

View more featured deals | all deals at Deal Monitor

Biotech

Blog in Blog: There are no posts that match the selection criteria.View more featured deals | all deals at Deal Monitor

Diagnostics

Blog in Blog: There are no posts that match the selection criteria.View more featured deals | all deals at Deal Monitor

Medical device

Blog in Blog: There are no posts that match the selection criteria.View more featured deals | all deals at Deal Monitor

Drug delivery

Blog in Blog: There are no posts that match the selection criteria.View more featured deals | all deals at Deal Monitor

Print Friendly, PDF & Email
cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new2gif
rauconbadgejpg
e78banner300x150animgif